Xcelerating Life Sciences Fireside Chat
Teresa Lavoie, principal at Fish & Richardson, speaks with Xconomy Managing Editor Dan Stanton about the legal complications of using machine learning and AI in discovering small molecule and biologic drugs, and how the patent landscape is likely to evolve.
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
PRA Health Sciences
